Woodford Patient Capital Share Discussion Threads

[jonwig] 14/1/2016 06:54

Adverse comment:

[topvest] 13/1/2016 19:45

Blimey - they have spent £800m on rubbish and have more targets lined-up. Extreme patience will be needed in my view. I do think that this vehicle will ruin his reputation.

[peterbill] 13/1/2016 18:47

Top 10 HoldingsProthena Corp PLC 4.90%Oxford Nanopore Technologies 4.54%Immunocore 0 4.42%Verseon 4.33%Proton Partners 3.98%Circassia Pharmaceuticals 3.80%Vernalis plc 3.67%Alkermes, Inc. 3.47%Oxford Science Innovations 3.05%IP Group PLC 2.81%

[tyranosaurus] 13/1/2016 10:07

Too large already.

[davr0s] 13/1/2016 08:36

They want more money - fear getting too large?

[liquidkid] 11/1/2016 16:42

Bingo Jackpot Hit - WingFnut Got high on his own supply. Used AI to tailor the
value of his personal unquoted super drug investment to 'Limitless' Certainly was ‘Finding value in complex data’



unquoted biotechnology firm Stratified Medical was the biggest single contributor of nearly 500 per cent to the strong outperformance of CF Woodford Equity Income in 2015

stratified medicine – personalised medicines – the tailoring of medical treatment to the individual characteristics of each patient.

Prothena, was the next biggest contributor after having rocketed 165 per cent in 2015

[tyranosaurus] 11/1/2016 13:18

NAV now 93.73p.
This must be a new low.

[fabius1] 08/1/2016 12:00

I think that's a bit harsh on Anthony Bolton. An excellent fund manager who had nothing to prove based on his track record at SS Fidelity. As a keen TA and fundamentals man I suppose he should really have known better. His big mistake was being lured out of retirement for that last fight. Bridge too far. Happens to the best. They allow the challenge to get the better of their judgement. Ironic re China as I recall he believed the much vaunted super cycle in commodities was over.

[my retirement fund] 07/1/2016 22:40

I suspect he is now yet another name thats quietly being consigned to the great dustbin of historical city slime as we speak.

[elmfield] 07/1/2016 20:55

Should have just stuck running Edinburgh inv etc.

[prewar] 07/1/2016 20:54

Oh dear is this PRTA another Woodford investment that is not going up in a straight line? LK can you just enlighten us with how PRTA has performed over say the period that WPCT has been created?

[liquidkid] 07/1/2016 14:53

BOOM! new year in and WooshFord hit with a 25% discount funding exhortion.

PRTA Prothena - An Irish pot-o-gold at the end of the rainbow type of Biotech investment

commenced an underwritten public offering of 2,250,000 of its ordinarys. In addition, Prothena has granted the undertakers an option up to an additional 337,500 shares. priced to the public of $53.00 (from $71)

Are you in mate? you gonna be diluted if ya not. Give ya a better price than Joe. Better take it up not goin to make the folio look too good if ya not playin.

On a side note saw one of the WooshFord Remnant following trading style:
So easy a baby can trade.

[dlku] 07/1/2016 08:46

NAV will be falling, hard not to in this market

[davr0s] 07/1/2016 08:24

At NAV now - be interesting if this holds now

[votiem] 06/1/2016 06:34

Just read Mad F's Dec 23 post - outstanding insights. Well done and thank you

[dlku] 04/1/2016 10:20

woody getting pasted on PURP, UTW and GMD

[liquidkid] 04/1/2016 10:19

Since you all read the DM - Midas Share tips for 2016

Alhalfa Minds ALM.L, a Woofood company (i.e. holds close to 30%, mysterious goings on between the two) Impious attack increased reverence. Near term certainty that it will bark this year.

Some of the text:

acquires great ideas

each could be worth hundreds of millions of pounds in their own right.

already generating revenue

expected to float at a significant valuation

could soon become substantial money-spinners

could become a very big company indeed

[p1nkfish] 29/12/2015 22:55

if you don't have the patience then just don't bother and go elsewhere.

there are some gems in the portfolio that will morecthan compensate for the duds.

[jonwig] 23/12/2015 15:07

This is an interesting discussion which I'm not really contributing to. I would have bought WPCT on the original premiss of £200m raise, but was advised to fold.

To what extent should one consider this versus a VCT? I contribute annually towards a VCT and get a 30% tax break in return for promising to hold for five years. Dividends (including r o c) are tax free and I don't need to declare them.

pro Woodford: he has healthcare/biotech expertise and is essentially fee-free with, he says, a longer timeframe than VCT managers. (I agree with these statements.)

pro VCT: the tax break is useful, as I have stuff which attracts extra SA tax. Choose a decent manager, and a conservative rather than aggressive fund, and you can make a decent total return over 5 years, which generally includes dividends. (Ignore AIM VCTs I suggest!) Watch their charges - they are high!

So, which? As it stands, I want to buy WPCT when it trades at a discount to NAV of maybe high single figures. After all, I get my VCT at a 21%+ discount right from the start. (30% less initial charges.)

[mad foetus] 23/12/2015 14:38

thanks for the positive feedback all.
On the downside, NWBO looks like a basket case - share price down 16% today on the back of fundraising news. Only 2.3% of the portfolio now, but I thought I would mention it before you know who does.

[the air marshall] 23/12/2015 12:58

Nobody's taking any notice of ceaserxzy, joseph moran, Liquid Kid and friends mainly because their posts are based on duff or incoherent information. It also smells of a concerted (but not very well run) campaign to pull the wool over our eyes. They're deliberately trying to confuse the two vehicles.

Mad foetus got at least 12 thumbs up for his great post! Carry on with the good work, mate. The bad guys will never win on this.....

[prewar] 23/12/2015 10:29

Liquid Kid got a new name? GMD is held by WEIF although not a particularly massive amount.

All the Woodford critics I think are expecting all the individual investments to be going up in straight lines uniformly.